Treatment of the Intermediate Vaginal Microbiota With Vaginal Lactobacillus Casei Rhamnosus to Improve Pregnancy Outcome

• Status: Completed
• Trial end date: 2020-12-30
• Target enrollment: 0
• Participant gender: Female

Summary

In the currently presented trial, investigators aim to evaluate the treatment of the intermediate vaginal microbiota during the first trimester of pregnancy with vaginal lactobacilli to restore the normal vaginal microbiota and therewith reduce the rate of PTD. All pregnant women between 10 + 0 (10 weeks plus 0 days) and 16 + 0 (16 weeks plus 0 days) gestational weeks in study group will be treated with vaginal Lactobacilli Capsules containing L. Casei rhamnosus LCR 35

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Medical University of Vienna

Criteria

Inclusion Criteria:

• Pregnant women 10th to 16th Week of gestation

Exclusion Criteria:

• Vaginal Bleeding, Twins, vaginal infections, Antibiotics up to 4 weeks to randomisation